601
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for 601, covering 2021-06-10 to 2025-12-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss [Phase 3]